Top Markets
Coin of the day
Caliway Biopharmaceuticals Co. L Caliway Biopharmaceuticals Co. L

Caliway Biopharmaceuticals Co. L

6919
주식 순위 #3556
Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated... Caliway Biopharmaceuticals Co., Ltd., and its affiliated entities, is dedicated to developing pharmaceuticals primarily in the fields of aesthetic medicine and chronic inflammation. Its lead investigational drug, CBL-514, is currently undergoing Phase 2 clinical trials, targeting non-surgical fat reduction, Dercum's disease, and cellulite. Beyond this, the firm is also progressing CBA-539 through preclinical exploration for potential applications in central obesity, hyperpigmentation, and skin aging. The company's offerings also extend to dietary supplements. Established in 2012, Caliway Biopharmaceuticals operates from its headquarters in New Taipei City, Taiwan.
주가
$3.28
마지막 동기화: 2026-07-31
시가총액
$5.10B
변동 (1일)
0.00%
변동 (1년)
-49.70%
국가
TW
거래 Caliway Biopharmaceuticals Co. L (6919)

카테고리

Caliway Biopharmaceuticals Co. L (6919)의 주가 이력
최고 종가: $3.30 (2026-07-01 기준)

최저 종가: $0.20 (2022-12-01 기준)
Caliway Biopharmaceuticals Co. L의 주가 이력 (2022 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -13.85%
2025 190.26%
2024 181.33%
2023 210.73%
2022 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$553.09 42.85%
US
$1.02K 44.02%
NL
$158.64 541.49%
US
$122.12 -12.63%
AU
$772.27 7.33%
CH